MULTIPLE SCLEROSIS - DIAGNOSTIC AND THERAPEUTIC APPROACHES: A LITERATURE REVIEW

Authors

DOI:

https://doi.org/10.47820/recima21.v5i2.4950

Keywords:

Multiple sclerosis. Diagnosis. Therapeutics

Abstract

Introduction: Multiple sclerosis (MS) is a progressive disease of the central nervous system with increasing global prevalence, representing a challenge for patients and health professionals. This study aims to address recent diagnostic and therapeutic strategies to improve the management of MS. Objective: To provide a comprehensive overview of diagnostic and therapeutic approaches to MS. Methods: A bibliographic review of the last 15 years was carried out in electronic databases, using specific inclusion criteria. Fifteen articles were selected after evaluating titles and abstracts. Results and Discussion: The increase in the incidence of MS globally and advances in diagnosis, including the role of magnetic resonance imaging and biomarkers, were highlighted. Conventional and emerging therapies were also addressed, emphasizing the importance of individualizing treatment and a multidisciplinary approach. Conclusion: Ongoing research and clinical trials are essential to fill knowledge gaps. A patient-centered approach, combined with scientific advances, promises to improve quality of life and clinical outcomes in MS.

Downloads

Download data is not yet available.

Author Biographies

Lucas Mainardo Rodrigues Bezerra

Instituto de Educação Superior do Vale do Parnaíba-IESVAP.

Fernando Akio Yamashita

Acadêmico de Medicina.

Júlia Lorena Lacerda Ferreira Pinho

Acadêmica de Medicina.

Jucimar Milhomem Coêlho Sobrinho

Acadêmico de Medicina.

Caio César Silva Rocha

Acadêmico de Medicina.

Caio Breno Reis Pires

Acadêmico de Medicina.

Gabriel Osaki Queiroz Urzedo

Acadêmico de Medicina.

Cleidson de Morais Silva

Acadêmico de Medicina.

References

BAR-OR, Amit et al. Teriflunomide and its mechanism of action in multiple sclerosis. Drugs, v. 74, p. 659-674, 2014. DOI: https://doi.org/10.1007/s40265-014-0212-x

BROWNLEE, Wallace J. et al. Diagnosis of multiple sclerosis: progress and challenges. The Lancet, v. 389, n. 10076, p. 1336-1346, 2017. DOI: https://doi.org/10.1016/S0140-6736(16)30959-X

CLAVELOU, Pierre. Can we optimize our teams? Multidisciplinary care for multiple sclerosis. Expert Review of Neurotherapeutics, v. 13, n. sup 2, p. 39-44, 2013. DOI: https://doi.org/10.1586/14737175.2013.865873

COHEN, Jeffrey A. et al. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. The Lancet, v. 380, n. 9856, p. 1819-1828, 2012. DOI: https://doi.org/10.1016/S0140-6736(12)61769-3

COMABELLA, Manuel; MONTALBAN, Xavier. Body fluid biomarkers in multiple sclerosis. The Lancet Neurology, v. 13, n. 1, p. 113-126, 2014. DOI: https://doi.org/10.1016/S1474-4422(13)70233-3

DENNISON, Laura; MOSS-MORRIS, Rona; CHALDER, Trudie. A review of psychological correlates of adjustment in patients with multiple sclerosis. Clinical psychology review, v. 29, n. 2, p. 141-153, 2009. DOI: https://doi.org/10.1016/j.cpr.2008.12.001

DEVONSHIRE, V. et al. The Global Adherence Project (GAP): A multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosis. European Journal of Neurology, v. 18, n. 1, p. 69-77, 2011. DOI: https://doi.org/10.1111/j.1468-1331.2010.03110.x

DOBSON, Ruth; GIOVANNONI, Gavin. Multiple sclerosis–a review. European journal of neurology, v. 26, n. 1, p. 27-40, 2019. DOI: https://doi.org/10.1111/ene.13819

EVANS, Charity et al. Adherence to disease‐modifying therapies for multiple sclerosis and subsequent hospitalizations. Pharmacoepidemiology and Drug Safety, v. 26, n. 6, p. 702-711, 2017. DOI: https://doi.org/10.1002/pds.4207

FEINSTEIN, Anthony et al. The link between multiple sclerosis and depression. Nature Reviews Neurology, v. 10, n. 9, p. 507-517, 2014. DOI: https://doi.org/10.1038/nrneurol.2014.139

FILIPPI, M.; PREZIOSA, P.; ROCCA, M. A. Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink? Curr Opin Neurol., v. 29, n. 3, p. 254-259, 2016.

FILIPPI, Massimo et al. Magnetic resonance techniques in multiple sclerosis: the present and the future. Archives of neurology, v. 68, n. 12, p. 1514-1520, 2011. DOI: https://doi.org/10.1001/archneurol.2011.914

FILIPPI, Massimo et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. The Lancet Neurology, v. 15, n. 3, p. 292-303, 2016. DOI: https://doi.org/10.1016/S1474-4422(15)00393-2

GALLIEN, Philippe et al. Multidisciplinary management of multiple sclerosis symptoms. European Neurology, v. 72, n. Suppl. 1, p. 20-25, 2014. DOI: https://doi.org/10.1159/000367620

GIOVANNONI, Gavin et al. A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. New England Journal of Medicine, v. 362, n. 5, p. 416-426, 2010. DOI: https://doi.org/10.1056/NEJMoa0902533

GOLDENBERG, Marvin M. Multiple sclerosis review. Pharmacy and therapeutics, v. 37, n. 3, p. 175, 2012.

HAUSER, Stephen L. et al. Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis. New England Journal of Medicine, v. 376, n. 3, p. 221-234, 2017. DOI: https://doi.org/10.1056/NEJMoa1601277

HAUSER, Stephen L.; CREE, Bruce AC. Treatment of multiple sclerosis: a review. The American journal of medicine, v. 133, n. 12, p. 1380-1390. e2, 2020. DOI: https://doi.org/10.1016/j.amjmed.2020.05.049

KALINCIK, Tomas. Multiple sclerosis relapses: epidemiology, outcomes and management. A systematic review. Neuroepidemiology, v. 44, n. 4, p. 199-214, 2015. DOI: https://doi.org/10.1159/000382130

LERAY, Emmanuelle et al. Epidemiology of multiple sclerosis. Revue neurologique, v. 172, n. 1, p. 3-13, 2016. DOI: https://doi.org/10.1016/j.neurol.2015.10.006

LIBERATORE, G. et al. Predictors of effectiveness of multidisciplinary rehabilitation treatment on motor dysfunction in multiple sclerosis. Multiple Sclerosis Journal, v. 20, n. 7, p. 862-870, 2014. DOI: https://doi.org/10.1177/1352458513508834

LUBLIN, Fred D. et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology, v. 83, n. 3, p. 278-286, 2014.

MARRIE, Ruth Ann et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Multiple Sclerosis Journal, v. 21, n. 3, p. 305-317, 2015. DOI: https://doi.org/10.1177/1352458514564487

MCGINLEY, Marisa P.; GOLDSCHMIDT, Carolyn H.; RAE-GRANT, Alexander D. Diagnosis and treatment of multiple sclerosis: a review. Jama, v. 325, n. 8, p. 765-779, 2021. DOI: https://doi.org/10.1001/jama.2020.26858

MONTALBAN, Xavier et al. Ocrelizumab versus placebo in primary progressive multiple sclerosis. New England Journal of Medicine, v. 376, n. 3, p. 209-220, 2017. DOI: https://doi.org/10.1056/NEJMoa1606468

ONTANEDA, Daniel; FOX, Robert J.; CHATAWAY, Jeremy. Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives. The Lancet Neurology, v. 14, n. 2, p. 208-223, 2015. DOI: https://doi.org/10.1016/S1474-4422(14)70264-9

PAGNINI, Francesco et al. Symptom changes in multiple sclerosis following psychological interventions: a systematic review. BMC neurology, v. 14, n. 1, p. 1-9, 2014. DOI: https://doi.org/10.1186/s12883-014-0222-z

PAPEIX, Caroline et al. Evaluation of an integrated multidisciplinary approach in multiple sclerosis care: A prospective, randomized, controlled study. Multiple Sclerosis Journal–Experimental, Translational and Clinical, v. 1, p. 2055217315608864, 2015. DOI: https://doi.org/10.1177/2055217315608864

POLMAN, Chris H. et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of neurology, v. 69, n. 2, p. 292-302, 2011. DOI: https://doi.org/10.1002/ana.22366

RIETBERG, Marc B. et al. Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trial. PloS one, v. 9, n. 9, p. e107710, 2014. DOI: https://doi.org/10.1371/journal.pone.0107710

RÍO, Jordi; COMABELLA, Manuel; MONTALBAN, Xavier. Multiple sclerosis: current treatment algorithms. Current opinion in neurology, v. 24, n. 3, p. 230-237, 2011. DOI: https://doi.org/10.1097/WCO.0b013e328346bf66

THOMPSON, Alan J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology, v. 17, n. 2, p. 162-173, 2018. DOI: https://doi.org/10.1016/S1474-4422(18)30168-6

TINTORE, Mar; VIDAL-JORDANA, Angela; SASTRE-GARRIGA, Jaume. Treatment of multiple sclerosis—success from bench to bedside. Nature Reviews Neurology, v. 15, n. 1, p. 53-58, 2019. DOI: https://doi.org/10.1038/s41582-018-0082-z

WALLIN, Mitchell T. et al. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology, v. 92, n. 10, p. e1029-e1040, 2019.

WATTJES, Mike P. et al. MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. The Lancet Neurology, v. 20, n. 8, p. 653-670, 2021. DOI: https://doi.org/10.1016/S1474-4422(21)00095-8

WATTJES, Mike P.; RAAB, Peter. Brain and spinal cord MRI in multiple sclerosis: an update. Neurology International Open, v. 1, n. 04, p. E294-E306, 2017 DOI: https://doi.org/10.1055/s-0043-118111

WILSKI, Maciej et al. Psychological factors associated with self‐management in multiple sclerosis. Acta Neurologica Scandinavica, v. 142, n. 1, p. 50-57, 2020. DOI: https://doi.org/10.1111/ane.13236

ZIEMSSEN, Tjalf et al. Optimizing treatment success in multiple sclerosis. Journal of neurology, v. 263, p. 1053-1065, 2016. DOI: https://doi.org/10.1007/s00415-015-7986-y

Downloads

Published

29/02/2024

How to Cite

Rodrigues Bezerra, L. M., Akio Yamashita, F., Lacerda Ferreira Pinho, J. L., Milhomem Coêlho Sobrinho, J., Silva Rocha, C. C., Reis Pires, C. B., … de Morais Silva, C. (2024). MULTIPLE SCLEROSIS - DIAGNOSTIC AND THERAPEUTIC APPROACHES: A LITERATURE REVIEW. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 5(2), e524950. https://doi.org/10.47820/recima21.v5i2.4950

Issue

Vol. 5 No. 2 (2024): CLICK HERE TO ACCESS THE ARTICLES

Section

ARTIGOS

Categories

License

Copyright (c) 2024 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores  e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.